Patent · US Active

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

US9066855B2 · kind B2 · utility

4Cited by

15References

18Claims

0Family size

Assignees

OTONOMY, INC. · US
The Regents of the University of California · US

Inventors

Jay Lichter · Rancho Santa Fe, US
Andrew M. Trammel · Olathe, US
Fabrice Piu · San Diego, US
Qiang Ye · San Diego, US
Benedikt Vollrath · San Diego, US
Luis A. Dellamary · San Marcos, US
Carl Lebel · Malibu, US
Jeffrey P. Harris · Village of La Jolla, US

Key dates

Filing date	Jun 26, 2013
Grant date	Jun 30, 2015
Priority date	—
Expiry date	Jun 26, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are thermoreverisble gel compositions containing a multiparticulate glutamate receptor antagonist, and methods for the treatment of otic diseases or conditions through intratympanic administration of the composition to an individual afflicted with an otic disease or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.